Chromatography remains the strategic centre of Aastrinz’s business, with PURSIL HPLC Columns serving as one of its flagship offerings
Er. Aryan Batra, Managing Director
Precision has always been fundamental to analytical science. Today, laboratories are being asked to deliver more than accurate results. Pharmaceutical, biotechnology, food, chemical and research organizations are looking for faster analysis, reproducible outcomes, greater automation, regulatory readiness and efficient workflows. This shift is strengthening demand for technologies such as high-performance liquid chromatography (HPLC), where advances in column chemistries, UHPLC and intelligent laboratory systems are improving analytical performance and throughput. According to Fortune Business Insights, the global HPLC market was valued at $5.36 billion in 2025 and is projected to reach $9.13 billion by 2034.
Within this evolving landscape, Aastrinz Life Sciences is positioning itself as an Indian chromatography and analytical laboratory solutions company combining product quality with application expertise and responsive technical support. Its portfolio spans HPLC systems and columns, syringe filters, laboratory consumables, sample preparation solutions and analytical laboratory equipment. At the centre of its strategy is PURSIL, its HPLC column brand, around which Aastrinz is building a broader chromatography ecosystem for pharmaceutical QC and R&D, chemicals, food testing, healthcare, clinical laboratories and research institutions.
“Rather than pursuing an expansive catalogue across unrelated laboratory categories, Aastrinz is taking a focused approach: deepen its chromatography capabilities, understand application-level challenges and build long term customer relationships through technical support”, speaks Er. Aryan Batra, Managing Director.
Closing a Critical Gap in Laboratory Solutions
The origins of Aastrinz Life Sciences can be traced to a practical problem its founders observed within the pharmaceutical industry. With experience in pharmaceutical procurement and laboratory quality products, including HPLC columns and consumables, the founding team saw laboratories depending considerably on international chromatography brands. Customers could encounter cost pressures, long delivery timelines and limited technical assistance once a product had been supplied.
Amit Wadhwa has been an important part of the company’s founding journey and has contributed to the foundation and growth of Aastrinz Life Sciences. The company was conceived to address market gaps through a focused chromatography proposition backed by accessible technical expertise and closer customer engagement.
Building credibility in a technically demanding segment was essential. Pharmaceutical QC and R&D laboratories are understandably cautious when adopting new chromatography products because consistency and reproducibility directly affect analytical outcomes.
“Aastrinz addressed this barrier by allowing customers to evaluate trial columns and by developing an in-house laboratory capability in Hyderabad. Where required, customers can provide samples for evaluation, enabling the company to conduct testing and share relevant HPLC and chromatographic results”, shares Rajasekhar Reddy, Managing Director.
This in-house application and testing facility remains an important differentiator, allowing customers to evaluate products against their analytical requirements rather than relying solely on product claims.
Making PURSIL the Core of a Chromatography Ecosystem
Chromatography remains the strategic centre of Aastrinz’s business, with PURSIL HPLC Columns serving as one of its flagship offerings. For an HPLC column, performance is ultimately measured by what happens repeatedly inside the laboratory. A column must deliver dependable separation, consistent peak characteristics and reproducibility across analytical runs.
PURSIL HPLC Columns are manufactured under the technical guidance of G. Rambabu, whose manufacturing and technical expertise supports the development of the column portfolio. Aastrinz places emphasis on silica quality, consistency and application suitability while continuing to expand PURSIL for different analytical requirements.
Its R&D efforts have resulted in offerings across multiple column categories and chemistries, including general-purpose and phenyl segments. An important development within the portfolio is CoroShield Technology (CST), which forms part of Aastrinz’s efforts to expand PURSIL through specialized column technologies for evolving analytical requirements.
The company’s chromatography strategy extends beyond columns. Sample preparation can substantially affect analytical reliability, as contaminants and particulates entering an HPLC system may influence results and compromise columns and other system components.
“Aastrinz consequently considers syringe filtration an integral part of its chromatography proposition. Our syringe filter portfolio is designed to support cleaner sample preparation, system protection and analytical reliability, with the company focusing on features including multi-layer filtration and supporting quality documentation”, shares Aryan Batra.
Other complementary categories include filtration products, safety caps and solvent-management solutions. The objective is to progressively create a connected portfolio around chromatography rather than become a general-purpose supplier across unrelated laboratory categories.
Competing Through Technical Depth, Not Just Products
The analytical instruments business is fundamentally different from conventional product distribution. Supplying the right specification is only the beginning; customers frequently require assistance with column selection, chromatographic behaviour, troubleshooting and method performance.
Aastrinz supports laboratories with application guidance, product selection, method-development assistance, troubleshooting and HPLC column training. Its technical team works with customers facing issues such as peak performance, injection consistency and column suitability, while its application experience helps recommend solutions for established analytical methods.
Requirements also vary by industry. Pharmaceutical laboratories emphasize reproducibility, quality control and regulatory requirements, while research laboratories require flexibility as methods evolve. Food, chemical and healthcare laboratories may prioritize speed, reliability, application suitability and cost efficiency.
“Aastrinz’s approach is therefore application-led. Instead of treating a column as a standardized commodity, our team seeks to understand factors such as required chemistry, expected peak characteristics, method conditions and desired column life before recommending a solution”, adds Rajasekhar Reddy.
Supporting this model is a team across technical support, R&D, marketing, quotations, finance, administration, billing and dispatch. S.K. Verma looks after Business Development, including customer relationships and business expansion, supporting Aastrinz’s efforts to deepen its market presence. Leadership also remains directly involved in customer and product-development activities, helping laboratory feedback reach technical and R&D teams quickly. Chromatography remains the strategic centre of Aastrinz’s business, with PURSIL HPLC Columns serving as one of its flagship offerings
R&D and AI as the Next Layer of Laboratory Innovation
As laboratories become increasingly digital, Aastrinz sees artificial intelligence as a forward-looking area of exploration and development rather than a commercially deployed technology within its current portfolio. AI is creating possibilities across intelligent data analysis, predictive maintenance, automated method optimization and experimental design.
For Aastrinz, potential applications being explored include analytical workflows, method development, technical support, process automation and operational efficiency. The objective is to understand where AI can reduce manual effort, development time and cost without compromising analytical quality or compliance.
The company views AI as an enabler of scientific capability rather than a replacement for technical expertise. In a field where analytical decisions have direct quality implications, domain knowledge and technology must ultimately work together.
Taking Indian Chromatography to a Wider Market
Aastrinz’s roadmap is built around specialization rather than diversification for its own sake. Its priorities include strengthening the PURSIL HPLC Column portfolio, including continued development of CST, expanding its syringe filter range, introducing advanced analytical solutions and investing in chromatography R&D.
The company is simultaneously pursuing a broader pan-India expansion strategy across major pharmaceutical and industrial clusters. Its growing presence includes Hyderabad, Bengaluru, Gujarat, Maharashtra, Baddi and other parts of Himachal Pradesh, Chandigarh, Dehradun and Haridwar. Strengthening its dealer and distributor network will be an important part of this national expansion.
International markets represent the larger long-term ambition. Aastrinz is working towards developing international partnerships and taking PURSIL HPLC Columns and its broader chromatography solutions to laboratories beyond India. Its vision is to establish Aastrinz as a trusted global chromatography and analytical laboratory solutions brand.
For decades, Indian laboratories have depended on international manufacturers for many high-value analytical and chromatography products. Aastrinz wants to participate in changing that equation by demonstrating the capabilities of an Indian chromatography brand supported by technical expertise, application knowledge and responsive customer engagement.
The journey, therefore, is about more than expanding a product catalogue. It is about building credibility around PURSIL, strengthening technical capabilities and developing a company laboratories associate with reproducibility, responsive support and application expertise. With chromatography firmly at the strategic centre of its business, Aastrinz is building around PURSIL through complementary syringe filtration, sample preparation and broader analytical laboratory solutions.
As analytical science moves toward faster, smarter and increasingly automated workflows, Aastrinz Life Sciences is betting that focused innovation, technical expertise and enduring customer relationships can give an Indian chromatography brand a meaningful place on the global laboratory map.
Aastrinz Life Sciences’ Competitive Edge